>cd05169 PIKKc_TOR TOR (Target of rapamycin), catalytic domain; The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases. TOR is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). TOR contains a rapamycin binding domain, a catalytic domain, and a FATC (FRAP, ATM and TRRAP, C-terminal) domain at the C-terminus. It is also called FRAP (FK506 binding protein 12-rapamycin associated protein). TOR is a central component of the eukaryotic growth regulatory network. It controls the expression of many genes transcribed by all three RNA polymerases. It associates with

Probab=90.16  E-value=1.1  Score=24.11  Aligned_cols=26  Identities=27%  Similarity=0.388  Sum_probs=20.6

Q ss_pred             EEECCCCCCCEEECC--CCCEEEECCCCC
Q ss_conf             440223464225627--960487316213
Q gi|254780795|r  186 IIHADLFPDNVLFYN--NKIMGLIDFYFS  212 (316)
Q Consensus       186 ~IHgDl~~~NiL~~~--~~i~giIDF~~~  212 (316)
T Consensus       183 lGlGDRH~~NILi~~~tG~vv-HIDFg~~  210 (280)
T cd05169         183 LGLGDRHPSNIMIDRLTGKVI-HIDFGDC  210 (280)
T ss_pred             EECCCCCCCCEEEECCCCCEE-EEECHHH
T ss_conf             131689864379986878789-9841665